Dorsal axial formation during vertebrate embryogenesis exhibits robust resistance to perturbations in patterning signals. However, how such stability is supported at the molecular level remains largely elusive. Here we show that Xenopus ONT1, an Olfactomedin-class secreted protein, stabilizes axial formation by restricting Chordin activity on the dorsal side. When ONT1 function is attenuated, the embryo becomes hyperdorsalized by a normally subeffective dose of Chordin. ONT1 binds Chordin and BMP1/ Tolloid-class proteinases (B1TP) via distinct domains and acts as a secreted scaffold that enhances B1TP-mediated Chordin degradation by facilitating enzyme-substrate association. ONT1 is indispensable for fine-tuning BMP signaling in the axial tissue, and a similar role has been suggested for dorsally expressed BMPs such as ADMP. Simultaneous inhibition of ONT1 and dorsally expressed BMPs (ADMP and BMP2) synergistically caused drastic dorsalization. These results indicate that stable axial formation depends on two compensatory regulatory pathways involving ONT1/B1TP and dorsally expressed BMPs.
INTRODUCTION
In Xenopus, once the dorsal-ventral (DV) polarity of the embryo is first determined by canonical Wnt signaling (reviewed in Heasman, 2006) , an orchestrated regulation of BMP activity then plays a central role in tissue patterning along the DV axis in the Xenopus gastrula. The level of local BMP signaling provides the ventral positional value in the embryonic field: high and low BMP signaling, respectively, specify the ventral and dorsal identities. These BMP signaling levels are finely controlled along the DV axis by positive (e.g., BMP ligands) and negative (e.g., BMP antagonists such as Chordin and Noggin) factors, which are interactively regulated at both the transcriptional and posttranslational levels (Khokha et al., 2005; Lee et al., 2006; reviewed in De Robertis and Kuroda, 2004) .
However, although many regulatory molecules have been identified, our understanding of their dynamic regulation as a network system is still limited. For example, although the organizer factor/neural inducer Chordin inactivates the major ventralizing factor BMP4 by binding to it in the extracellular space (Piccolo et al., 1996) , their functional and transcriptional relationships are not simple. For instance, in the reverse direction, BMP4 suppresses Chordin expression (Reversade and De Robertis, 2005) . This mutual regulation, if working alone, would cause a problem in the graded pattern formation of the embryo, because such a double-inhibitory relationship functions as a positive-feedback loop, which is unstable by nature and tends to cause catastrophic changes (Gardner et al., 2000) . In this imaginary situation, a small increase in Chordin would cause reduced BMP activity, which in turn would desuppress (increase) Chordin expression. As a result of such a chain reaction, the dorsal signal (Chordin) would eventually predominate.
Contrary to such theoretical instability, the embryonic dorsal axial pattern exhibits substantial resistance (or robustness) to quantitative change in the level of patterning signals such as Chordin (Reversade and De Robertis, 2005) . In addition, classic studies in experimental embryology provide several lines of evidence for the robustness of dorsal axial patterning. First, the Spemann organizer differentiates into the notochord (the original fate of dorsal axial mesoderm) even after it is grafted to the ventral-most part of the marginal zone (Spemann and Mangold, 1924) , where the highest level of ventralizing signals is supposedly present. In addition, normal development of the Xenopus tadpole is observed even after a substantial ablation or addition of organizer tissue at the early gastrula stage (Cooke, 1973 (Cooke, , 1975 . In the avian embryo, the dorsal axis is restored even after total ablation of the node (Gallera and Nicolet, 1974; Joubin and Stern, 1999) . Another example is the bisection experiment in amphibian embryos. When an amphibian blastula is bisected into dorsal and ventral halves, the dorsal half (which supposedly lacks ventral information) develops into a small but normally patterned embryo that contains both dorsal and ventral structures, whereas the ventral half develops only into pattern-less ventral tissues called belly pieces (Reversade and De Robertis, 2005; Spemann, 1903) . These findings indicate that a self-regulating fail-safe system exists on the dorsal side of the amphibian embryo.
Recent studies have implicated a BMP ligand, ADMP (antidorsalizing morphogenetic protein), in the feedback regulation of the Chordin/BMP system on the dorsal side (Dosch and Niehrs, 2000; Joubin and Stern, 1999 ; Lele et al., 2001 ; Moos et al., 1995; Reversade and De Robertis, 2005) . ADMP expression is found in dorsal axial tissues in a manner similar to Chordin, and is negatively regulated by BMP signals (Dosch and Niehrs, 2000; Reversade and De Robertis, 2005) . Conversely, the BMP ligand ADMP contributes to the sum of ventralizing BMP signals, which reduce the gene expression of the organizer factors (Moos et al., 1995; Reversade and De Robertis, 2005) . This feedback loop is thought to contribute to the stabilization of DV patterning by preventing the unlimited expansion of dorsal axial mesoderm. However, ADMP by itself can only account for part of the feedback regulation, because the knockdown of ADMP by MO injection causes only moderate (noncatastrophic) dorsalization (Reversade and De Robertis, 2005 ; also this paper).
In this study, we introduce Xenopus ONT1 as a key molecule for fine-tuning of the Chordin/BMP system, and show its essential role for the posttranslational regulation of Chordin. ONT1 belongs to a newly identified group of secreted proteins, called the Olfactomedin family (Zeng et al., 2005 ; see Figure S1A available online), whose biological roles remain largely elusive. Olfactomedin-family proteins have a coiled-coil domain (which is relatively diverse in its amino acid sequence) in the amino-terminal half and a conserved Olfactomedin domain in the carboxy-terminal half (Tsuda et al., 2002) . Two Olfactomedin-related factors were previously reported to play a regulatory role in neural development. Noelin is expressed in the neural crest and prolongs the generation period of neural crest production (Barembaum et al., 2000) . Tiarin is expressed in the nonneural ectoderm adjacent to the anterior neural plate and induces dorsalization of the nervous tissues (Tsuda et al., 2002) .
We recently isolated a chick Olfactomedin-family factor, ONT1, which is distantly related to Noelin and Tiarin (Sakuragi et al., 2006) . Chick ONT1 is expressed in the axial and paraxial mesoderm during early chick embryogenesis (Sakuragi et al., 2006) . To explore the possible roles of the Olfactomedin family in axial patterning, we isolated a homolog in Xenopus (GenBank, EMBL, DDBJ accession number AB440138; see Supplemental Experimental Procedures), an animal model that allows detailed molecular analysis of DV patterning (Heasman, 2006; De Robertis and Kuroda, 2004 ). Here we demonstrate that ONT1 is a unique pro-BMP factor that acts as a secreted scaffold for the B1TP-mediated degradation of Chordin. We show that ONT1 functions as a key player in the dynamic control of Chordin protein levels. Finally, we propose that ONT1, together with dorsally expressed BMPs, plays an indispensable role in Chordin activity regulation and ensures stable DV patterning in the embryo.
RESULTS
Xenopus ONT1 Is an Olfactomedin-Family Secreted Factor Expressed on the Dorsal Side of the Embryo Xenopus ONT1 encodes a secreted protein (392 amino acids long) that contains a coiled-coil domain and an Olfactomedin domain ( Figure 1A ; these domains have 72% and 75% amino acid identity, respectively, to those in the chick homolog). The Olfactomedin domain of ONT1 shows moderate homology with those of Noelin and Tiarin, whereas the coiled-coil domain is less conserved. Recombinant ONT1 protein was efficiently secreted into the culture medium by HEK293T cells overexpressing it and also by dissociated cells of ONT1-injected Xenopus embryos ( Figure S1B ; most secreted ONT1 appeared as a dimer; lanes 4 and 8).
In whole-mount in situ hybridization analyses, ONT1 expression appeared at the late blastula stage with diffuse labeling in the animal region ( Figure S1C ). At the early gastrula stage, ONT1 was expressed in the deep dorsal mesoderm (not in the superficial zone) whereas its diffuse expression in the animal cap was fading ( Figure 1B ). The expression in the dorsal mesoderm continued during the mid-to-late gastrula stages ( Figure 1C ). During the late gastrula and neurula stages, ONT1 expression was observed in the axial and paraxial mesoderm ( Figures 1D, S1D , and S1E), including the head mesoderm, consistent with ONT1 expression in early chick embryos (Sakuragi et al., 2006) .
Attenuation of ONT1 Function Causes Dorsalization
To elucidate the in vivo function of ONT1, we performed loss-offunction experiments in Xenopus using ONT1-MO (see Figures  S2A-S2C for the design and specificity of this test). Injection of ONT1-MO induced the typical signs of dorsalization such as a larger head and short body with thick dorsal structures in the late tailbud embryo (73%, n = 70; Figure 1F ). During the midto-late gastrula stages, ONT1-MO caused expansion of the dorsal axial marker Goosecoid (Gsc; 100%, n = 20; Figures 1G and  1K ), whereas injection of the control MO with five-base mismatches had no effect (n = 14; Figures S2F and S2G ). ONT1-MO injection also expanded the expression of the dorsal axial markers Chordin (100%, n = 12; Figures 1H and 1L) and Shh (93%, n = 14; Figures 1I and 1M) as well as the expression of the anterior neural plate markers Xanf and Otx2 (90%, n = 20 and 95%, n = 20, respectively; Figures S2D and S2E and not shown; in Xenopus, augmentation of early organizer activity causes both dorsalization and anteriorization due to head organizer induction). In contrast, ONT1-MO reduced Sizzled (Szl; a ventral marker) expression (83%, n = 18) on the ventral side ( Figures 1J and 1N) . The ONT1-MO-induced dorsalization phenotypes (expansion of Gsc, Chd, and Shh, and suppression of Szl) were reversed by coinjecting a small amount (4 pg) of MO-resistant ONT1 RNA (with silent mutations; Figures 1O-1R ). The expansion of dorsal gene expression (Gsc) was observed when ONT1-MO was injected into the dorsal blastomeres of four-cell embryos (88%, n = 17; Figure 1S ), but not into the ventral ones (n = 19; Figure 1T ), indicating that dorsally expressed ONT1 is required for proper axial patterning.
These findings suggest that ONT1 is required for regulating the level of dorsalization in dorsal embryonic tissues. Figure 2C , lane 5), which are known to degrade Chordin protein (Blitz et al., 2000; Piccolo et al., 1997) . Importantly, the coimmunoprecipitation of ONT1 with Chordin ( Figure 2E , lane 3) or BMP1 ( Figure 2F , lane 3) was also observed using the secreted fraction from a dissociation culture of RNA-injected Xenopus embryonic cells. Analyses using deletion mutants ( Figure 2G ) revealed that the Olfactomedin domain of ONT1 ( Figure 2A , lane 7), but not its coiled-coil domain ( Figure 2A , lane 6), bound to Chordin, indicating that ONT1 physically interacts with Chordin in a domain-specific manner. In contrast, the coiled-coil domain of the ONT1 protein interacted with the two B1TP proteins (Figures 2B and 2C, lane 6) . ONT1 also binds to the Chordin-BMP4 complex in vitro ( Figure S4C ), and the association between ONT1 and Chordin is not strongly affected by the addition of BMP4 and/or Tsg protein (at an equimolar dose to Chordin; Figure S4D ).
These observations show that ONT1 binds to Chordin and B1TP via distinct domains ( Figure 2H ).
Loss of ONT1 Function Impairs the Robustness of Embryonic Patterning against Increased Chordin Levels
The physical association between Chordin and its proteolytic enzymes raised the possibility that ONT1 plays a role in modulating extracellular BMP signaling via Chordin. Interestingly, embryonic DV patterning shows substantial resistance to quantitative changes in Chordin protein. The blastocoele injection of recombinant Chordin protein in the Xenopus blastula causes minimal change in the axial pattern (Reversade and De Robertis, 2005) . We examined whether the depletion of ONT1 would affect this robust resistance of DV patterning to increased Chordin ( Figure 3A) .
Consistent with the previous report, injected recombinant Chordin protein (44 fmol/blastocoele; which is sufficient to reverse the strong ventralizing effect of 22 fmol BMP4; Figures S5A and S5B) at stage 9 caused only weak dorsalization, if any, at this dose: a marginal increase in Gsc expression and little change in the expression pattern of the anterior forebrain marker Rx (compare Figures 3D and 3H with Figures 3B and 3F ). In contrast, when ONT1-MO was injected in advance, the Chordin protein injection caused a dramatic increase in Gsc expression (96%, n = 26; Figure 3E ) and a marked expansion of Rx expression (extending even to the ventral and posterior side; 96%, n = 26; Figure 3I ). Similar hyperdorsalization phenotypes in ONT1-MO-injected embryos were observed when Chordin was injected at stage 11 ( Figures S5C-S5F ). Coinjection of MO-resistant ONT1 RNA (silent mutation) inhibited hyperdorsalization caused by Chordin and ONT1-MO (no drastic Gsc expansion in 87%, n = 15; Figure S5H ). ONT1-MO injection experiments into dorsal-or ventral-specific blastomeres showed that the loss of ONT1 function on the dorsal side caused severe hypersensitivity to injected Chordin protein ( Figures S5I and S5K ), (E and F) Xenopus embryos given an injection of Chordin mRNA (400 pg) and ONT1-Flag mRNA (400 pg) (E), or BMP1 mRNA (500 pg) and ONT1-Flag mRNA (300 pg) (F). RNA-injected embryos were dissociated into CMFM (calcium/magnesium-free medium) at stage 10.5, and the conditioned medium was harvested at stage 13. (G) Schematic of ONT1 and ONT1-deletion constructs. (H) ONT1 binds to BMP1 via the CC and to the CR2-4 region of Chordin via the OLF.
whereas ventral injection sensitized the embryo to only a minor extent ( Figures  S5J and S5L ).
These findings indicate that ONT1 function is indispensable for the robustness of dorsal patterning with respect to the Chordin-regulated mechanism.
ONT1 Promotes BMP1-Mediated Chordin Degradation as a Secreted Scaffold
Because the in vivo expression of ONT1 overlaps with the expression of Chordin and the B1TP genes (BMP1 and Xlr; Figure S6 ), we became interested in the possibility that ONT1 might promote BMP1-mediated Chordin degradation by acting as a secreted scaffold (or an adaptor protein; reviewed in Burack and Shaw, 2000; Ferrell, 2000) of the proteinase and its substrate, Chordin.
In the in vivo experiment, we coinjected Chordin RNA with a moderate dose of BMP1 RNA that is sufficient for only a partial reduction of the Chordin protein in the extracellular fraction (Figures 4A and 4B, lanes 2 and 3) . If the scaffold model is correct, the appropriate doses of ONT1 should promote Chordin degradation. In contrast, excessively high doses of ONT1 should inhibit degradation because the ONT1 proteins would bind individually to each protein, leading to the segregation of Chordin and BMP1 ( Figure 4D ). Consistent with these predictions, the coinjection of ONT1 (up to 100 pg/embryo) reduced the Chordin level in a dose-dependent manner ( Figure 4B , lanes 3-7; Figure 4C) , whereas the injection of higher doses of ONT1 dosedependently increased undigested Chordin, resulting in Chordin levels comparable to those of the BMP1-uninjected control ( Figure 4B , lanes 2 and 8-10; Figure 4C ).
Similar biphasic effects (dose-dependent facilitation and inhibition) of ONT1 on B1TP-mediated Chordin degradation were also observed in the in vitro assay using HEK293T-produced proteins ( Figure 4E ; Xlr was used in this assay by the reasoning described in Experimental Procedures). Importantly, when a low-molecular-weight peptide ligand for B1TP was used (Lee et al., 2006) , the addition of ONT1 protein did not affect the enzymatic activity ( Figure 4F ), indicating that the enhancement of cleavage is a substrate-(Chordin) specific phenomenon.
Another prediction from this scaffold model is that a higher dose of the enzyme should shift the window for the optimal ONT1 doses. To test this, we titrated ONT1 in the in vitro digestion assay of Chordin using three different doses of Xlr ( Figure 4G ; the amounts of the digested amino-terminal fragment were quantified; Figure S7A ). In the presence of higher doses of Xlr (green and red), facilitation of Chordin digestion was observed even at higher concentrations of ONT1 ( Figure 4G , lanes 5 and 6), at which the inhibition of proteolysis was seen when a low dose of Xlr (blue) was used ( Figure 4H illustrates the ratios to the zero-ONT1 control shown in lane 2), showing that the optimal range of ONT1 was shifted (or widened) to the higher direction. Consistent with the binding data ( Figure S4D ), the presence of BMP4 and/or Tsg protein does not substantially affect the enhancement of Xlr-mediated Chordin degradation by ONT1 in vitro ( Figure S4E) .
To obtain direct molecular evidence for the scaffold model, we attempted to isolate and analyze the enzyme-substrate complex (so-called Michaelis complex) of Chordin and B1TP, but it was not detectable in western blots (data not shown), presumably because of the low abundance of the transient intermediate complex. To stabilize the enzyme-substrate complex by preventing its hydrolysis, we next used a dominant-negative BMP1 (dnBMP1; mutated BMP1 according to tolloid mutation; following Piccolo et al., 1997) . Epitope-tagged ONT1, Chordin, and dnBMP1 proteins were separately overproduced in HEK293T cells and purified with Ni-NTA beads from conditioned medium. Immunoprecipitation assays of dnBMP1 (using a Flag antibody) showed that the association of dnBMP1 and Chordin substantially increased when a small amount of ONT1 was present (compare lanes 3 and 4 in Figures  4I and 4J ). In contrast, as predicted from the model in Figure 4D , excessive amounts of ONT1 interfered with the binding of dnBMP1 and Chordin ( Figures 4I and 4J, lanes 8 and 9 ). These observations demonstrate that, at an appropriate dose, ONT1 indeed functions as a binding scaffold that promotes enzyme-(B1TP) substrate (Chordin) association.
We further confirmed the secreted scaffold model in the in vivo context. First, if the model in Figure 4D is correct, a simultaneous partial reduction of ONT1 and B1TP proteins should synergistically reduce Chordin degradation and thereby promote dorsalization in the embryo. We therefore performed coinjection experiments of BMP1-MO and ONT1-MO. When each MO was injected separately at a low dose (half of the effective dose), no substantial expansion of Gsc expression was seen ( Figures  S7C and S7D) . However, when the two MOs were combined, they strongly increased Gsc expression in the injected embryo (92%, n = 12; Figure S7E ) to a level greater than that seen with ONT1-MO or BMP1-MO alone at higher doses, indicating that ONT1 and B1TP cooperatively regulate Chordin levels.
Second, this scaffold model predicts that the presence of excessive ONT1 (which causes the sequestration of Chordin and B1TP) should result in dorsalization, instead of ventralization, due to the reduction of B1TP-mediated Chordin degradation. Indeed, overexpression of ONT1 caused dorsalization in the embryo instead of ventralization (100%, n = 28; Figure 5B ). ONT1 overexpression increased the dorsal marker Gsc (77%, n = 30; Figure 5D ) and suppressed the ventral marker Szl (100%, n = 23; Figure 5F ). Consistent with this idea, in the ONT1-MO injection experiments, coinjection of a small amount of ONT1 RNA (4 pg is optimal) rescued the expression of Gsc and Szl, whereas high doses of ONT1 injection expanded Gsc expression and suppressed Szl expression ( Figures S2H-S2Q ). Overexpression of ONT1 reversed the ventralization phenotype induced by BMP1 (Figures 5G-5J ; Figure 5J shows an example of the normalized embryos counted in Figure 5G ), but not the ventralization caused by a constitutively active form of BMPR ( Figures 5K and 5L) , suggesting that ONT1 acts somewhere between BMP1 and BMP receptors (consistent with the BMP1-Chordin system). In addition, ONT1 overexpression did not substantially reverse the ventralization caused by Chordin-MO (n = 20; Figures 5M-5O) , suggesting that the dorsalizing effect of ONT1 overexpression requires Chordin. These findings demonstrate that the overexpression phenotypes of ONT1 are also related to the B1TP-Chordin system. ONT1 overexpression did not interfere with either Wnt8-induced axis duplication in vivo or Xnr1-induced mesodermalization in the animal cap assay (Figures S8A-S8C ).
Taken together, these observations support the idea that ONT1 acts as a secreted scaffold that promotes Chordin degradation by B1TP.
ONT1 and ADMP Function Together in a Dual-Safety Stabilizing System for Axial Patterning
We next examined the regulation of ONT1 expression by BMP signaling and compared it with the transcriptional control of relevant genes ( Figure 6A ). ONT1 expression was substantially increased (3.3-fold) by the injection of BMPs-MO (mixed MOs for four BMPs; Reversade and De Robertis, 2005 ) and suppressed by BMP4 in the late gastrula embryo ( Figure 6A, lanes  1-3) . These results demonstrate that the expression of ONT1 at this stage is negatively regulated by ventralizing (BMP) signals, as is the expression of Chordin (lanes 4-6) and ADMP (lanes 7-9; its expression is extremely sensitive to BMP attenuation, as reported by Reversade and De Robertis, 2005) . The expression of the ventral gene Szl was regulated in the opposite manner (lanes 16-18). In contrast, the level of BMP1 expression appeared less dependent on BMP signaling; it showed relatively little change upon reduction in BMP signals (lanes 13 and 14) and was only partially suppressed by BMP4 (lane 15).
The dorsally expressed BMP ligand ADMP has been implicated in the feedback control of the Chordin/BMP system for dorsal patterning as a balancer molecule (Reversade and De Robertis, 2005) . Importantly, the two pro-BMP factors ADMP and ONT1 evidently differ in their modes of action. ADMP works by binding to BMP receptors whereas ONT1 acts via Chordin degradation. Therefore, we next performed a double-knockdown study to examine the possible functional relationship between ONT1 and ADMP. The single injection of ONT1-MO (12.5 ng) or ADMP-MO (3 ng) caused a relatively moderate increase in Gsc expression (Figures 6C and 6D) in the gastrula (the increase was 3-fold for each MO by quantitative RT-PCR; Figure 6F ). In contrast, coinjection of ONT1-MO and ADMP-MO led to a very strong induction of Gsc (100%, n = 15; Figures 6E and 6F; 20-fold by quantitative RT-PCR), indicating that the two MOs worked together in a synergistic (nonlinear) fashion. Consistent with this idea, the embryos injected with both MOs exhibited a severe dorsalization and anteriorization phenotype: enormous expansion of the head (see the expansion of Rx expression and the caudal shift of Krox20 expression; 100%, Figure 6H ) and marked enlargement of the dorsal axial marker Shh (100%, n = 19; Figure 6J ). (The modest phenotypes in single MO injections may be partly explained by the fact that ONT1-MO increased ADMP expression whereas ADMP-MO induced ONT1 expression; Figure S9A .) Coinjection of Chordin-MO reversed the hyperdorsalization phenotypes induced by the double knockdown of ONT1 and ADMP (reversion in Gsc expression, 100%, n = 12 and in the mixed probe pattern, 100%, n = 14; compare Figures 6K and 6L with Figures 6E and 6H ). These findings support the idea that ONT1 and ADMP both participate in the Chordin/BMP regulatory network, presumably in two parallel compensatory pathways.
Given that ONT1 acts through B1TP activity, B1TP-MO should mimic ONT1-MO with respect to the double-knockdown phenotype with ADMP. Indeed, whereas the knockdown of two B1TPs (BMP1 and Xlr) had only a moderate effect (no strong expansion of Gsc expression, n = 12; compare Figures 6B and 6M) , the simultaneous knockdown of B1TPs and ADMP cooperatively caused a strong expansion of Gsc expression in the gastrula (100%, n = 12; Figure 6N ), as was seen with the double knockdown of ONT1 and ADMP ( Figure 6E) . Thus, the simultaneous block of ADMP and either ONT1 or B1TP resulted in a marked shift toward hyperdorsalization. Together, these results indicate that the regulative development of dorsal axial tissues requires the unique secreted scaffold ONT1, which contributes to the robust stability of axial patterning in concert with B1TP and ADMP on the dorsal side.
Interestingly, we also observed that the ventrally expressed B1TP antagonist Szl competed with ONT1 for B1TP binding. This mechanism may further restrict ONT1 function along the DV axis ( Figure S9B , lanes 3 and 4; Lee et al., 2006; Muraoka et al., 2006; Salic et al., 1997) .
Redundant Roles of BMP2 and ADMP in Dual-Safety Regulation Although the expansion of dorsal markers such as Gsc by ONT1-MO and ADMP-MO was thus drastic, the expansion of axial Shh + tissues (the dorsal-most tissues) was still largely confined to the proximity of the dorsal midline region ( Figure 6J ). Therefore, we presumed that, in addition to ADMP, some other BMP factors might be involved in the robust stability of dorsal axial patterning.
A strong candidate for this role is BMP2, whose expression, like ADMP expression, was induced by BMPs-MO and suppressed by BMP4 injection in the late gastrula embryo ( Figure 6A, lanes 10-12) . This regulation of BMP2 expression may reflect its in vivo expression in the anterior-most region of the embryo (anterior mesendoderm derived from the dorsal lip) during the gastrula stages (stage 11 and onward: Figures S10C-S10F and S10M; compare with ADMP expression in Figures S10G-S10L) . Upregulation of BMP2 expression by BMPs-MO injection was also observed by in situ hybridization at stage 11, whereas BMP4 injection suppressed it (Figures S10M-S10O). More importantly, the double knockdown by ONT1 and ADMP caused strong induction of BMP2 expression (83%, n = 18; Figures 7A and 7B; stage 11.5). These observations raised the possibility that BMP2 participates in feedback regulation in a partially overlapping fashion with the function of ADMP.
Consistent with this idea, the double knockdown of ADMP and BMP2 induced a substantial upregulation of Gsc and Shh expression (100%, n = 12 and 100%, n = 11, respectively; Figures 7E and 7F), suggesting that BMP2 and ADMP have partially redundant roles. However, as was also seen with the doubleknockdown phenotype of ADMP and ONT1, the expansion of the dorsal axial marker Shh was still limited to the neighboring regions of the normal expression sites ( Figure 7F ). In contrast, the triple knockdown of ADMP, BMP2, and ONT1 caused a severe expansion of Gsc and Shh expression (100%, n = 14 each; Figures 7G and 7H ). These findings indicate that the stabilization mechanism of axial development nearly collapsed on the dorsal side in this triple knockdown.
Collectively, the experimental results in this study clearly demonstrate the presence of a dual-safety mechanism for stable dorsal axial patterning that involves two parallel mechanisms involving ONT1/B1TP pathway and ADMP/BMP2 loop ( Figure S10P ).
DISCUSSION

ONT1 as a Secreted Scaffold for Facilitated Chordin Degradation
This report introduces ONT1 as a novel type of pro-BMP regulator that acts in the extracellular signaling network, that is, as a secreted scaffold for Chordin degradation. An important unique property of ONT1 is that it is a secreted scaffold that interacts with extracellular enzymes, unlike the previously reported scaffolds, which function with intracellular proteins (e.g., kinases; Whitmarsh et al., 1998) . This study shows that ONT1 promotes Chordin-BMP1 association in vitro ( Figures 4I and 4J ). Whether ONT1 may also act by increasing enzymatic turnover (i.e., as a catalytic scaffold) is a challenging, unresolved question that requires extensive enzymological analyses.
Besides its quantitative role in promoting Chordin degradation, ONT1 may also have a qualitative role as a scaffold that involves substrate specificity regarding its mode of action. Several other molecules including collagen have also been suggested as candidate in vivo substrates of B1TP (reviewed in Ge and Greenspan, 2006) . It is therefore possible that the substrate-selective nature of ONT1's action is important for specifically promoting Chordin degradation by B1TP in vivo, where these competitive substrates are present.
We have so far been unable to obtain an accurate quantification of endogenous ONT1 protein by a strong specific antibody. In our preliminary experiment, we injected a small amount of ONT1 RNA (0.125-8 pg at the four-cell stage; note that 4 pg is optimal for the rescue experiment in Figure 1 ) to see whether a small increase in ONT1 level would slightly ventralize (instead of dorsalize) the embryo by enhancing Chordin degradation. However, no obvious ventralization (increase in Szl) was seen with an ONT1 injection at any dose ( Figure S2R ); in fact, the expression of the ventral marker decreased. One possible interpretation is that the in vivo level of endogenous ONT1 is already close to the optimal concentration and that its further increase results in B1TP inhibition.
Reinforcement of Dorsal Axial Pattern Stability by ONT1
In embryos with decreased ONT1 function, the injection of a subeffective dose of Chordin protein led to substantial instability in dorsal axial specification and caused hyperdorsalization (Figure 3) . The attenuation of ONT1 function also strongly sensitized the response of the embryo to decreased ADMP and BMP2 signals (Figures 6 and 7) . In contrast, ONT1 does not bind to Noggin ( Figure S3I ), and ONT1-MO injection showed relatively little synergism with Noggin injection (Figures S5M-S5P) .
The presence of both dynamic flexibility and strong robustness in the same integrated system is a fundamental characteristic of living organisms. Multiple strategies can theoretically work together to reinforce the stability (or robustness) of a system against the substantial perturbation of critical parameters. These include feedback regulation, redundancy, and compartmentalization (Kitano, 2007; Niehrs and Meinhardt, 2002) . Compartmentalization of the regulatory system into multiple modules limits the effects of a break in stability to within the compartment, preventing it from influencing the entire system. BMP-depletion experiments ( Figure 6A ) suggest that the level of ONT1 expression could be regulated in a negative feedback loop at least during late gastrulation. Double-knockdown experiments showed that ONT1 and ADMP function in a redundant manner ( Figure 6 ). With respect to compartmentalization, ONT1 and ADMP do not overlap in their modes of action (an enzyme-substrate scaffold and a BMP ligand) and, therefore, can function as regulators at different levels (i.e., as distinct functional modules). Moreover, the two modules may also function in a mutually compensatory fashion via transcriptional control ( Figure S9A ). This coupling of two functional modules further reinforces the stability of the system against perturbation in a fail-safe manner (Horikawa et al., 2006;  Figure S10P ).
Spatial and Temporal Regulation by ONT1 and ADMP/BMP2 In Vivo
The spatial and temporal expression patterns of other regulators in the Chordin/BMP system are also dynamic. In normal embryos, ADMP expression is mostly limited to the axial tissue, where Chordin expression is highest (Figures S10G-S10L ). In contrast, ONT1 expression is not limited to the axial mesoderm even at the late gastrula stage, and it is also expressed in the paraxial mesoderm ( Figures 1D, S1D , and S1E; data not shown). Thus, ONT1 may also promote Chordin degradation at a distance from the site of Chordin expression, whereas ADMP normally forms a negative feedback loop close to the dorsal midline. Upon the substantial perturbation of DV patterning signals, however, both ONT1 and ADMP are likely to function beyond their normal ranges (Figures 6 and 7) and together equilibrate local BMP signaling.
Part of ADMP's role appears to be compensated for by another BMP ligand, BMP2, whose expression is regulated by dorsal influences (Figures 7 and S10) . The dynamic BMP2 expression in the anterior region may contribute to the stabilization of DV positional values in rostrally migrating dorsal cells, including head organizer cells, during transitional phases. Interestingly, the anterior expression of Xlr largely overlaps with that of BMP2 during midgastrulation ( Figure S6E ).
With respect to the timing of action for DV pattern stability, the classic embryological study (organizer deletion and addition) has shown the presence of strong robustness in axial specification even after the onset of gastrulation in Xenopus (Cooke, 1973 (Cooke, , 1975 , although a previous study using Smad-GR suggested that BMP signaling has stronger effects on DV patterning at the pregastrula stage than after it (Marom et al., 2005) . Interestingly, blastocoele injection of Chordin protein at stage 11 also caused hyperdorsalization when combined with ONT1-MO injection ( Figures S5C-S5F) , suggesting that the dynamic Chordin/BMP system (including ONT1-mediated robustness) controls dorsal axial patterning during the gastrula stages.
Possible Roles of ONT1 in Nonaxial DV Patterning Thus, the role of ONT1 is consistent with the classic bisection experiment showing that the main regulative mechanism of dorsal axis formation exists on the dorsal side, rather than the ventral side, which forms only a belly piece when grown alone. On the ventral side, a number of BMP4 synexpression group genes including Szl (Niehrs and Pollet, 1999) seem to contribute to the stabilization of ventral identity via mutual regulation: this ventral system, which forms its own self-regulatory compartment, has also been referred to as the ''ventral signaling center'' (Reversade and De Robertis, 2005; Plouhinec and De Robertis, 2007) .
A working hypothesis for the possible integration of dorsal and ventral factors in the Chordin/BMP system is illustrated in Figure S11 . Based on this and previous studies, we deduce that the mechanism of the entire DV patterning process involves two related but distinct regulations of stability: ''robustly stable axial formation and maintenance'' in the axial (organizer) region, and ''dynamic and flexible pattern generation and maintenance'' in the nonaxial (nonorganizer) marginal zone.
EXPERIMENTAL PROCEDURES
Embryonic Manipulation, Microinjection, and RNA Analysis Embryos received mRNA or MO injections four times radially at the four-cell stage unless mentioned otherwise. Antisense MOs for Xenopus laevis ONT1, BMP1, and Xlr were obtained from Gene Tools. Blastocoele injection was performed as described (Pera et al., 2003) . Blastula embryos were injected into the blastocoele cavity with 40 nl of recombinant mouse Chordin (44 fmol; R&D Systems), human BMP4 (22 fmol; R&D), and mouse Noggin/Fc (22 fmol) in 0.13 Barth medium containing 0.1% BSA. Quantitative RT-PCR was performed on the 7500 Fast Real-Time PCR system (Applied Biosystems) using the Power SYBR Green PCR Master Mix (Applied Biosystems). Detailed information is available in Supplemental Experimental Procedures.
Immunoprecipitation Assays
For coprecipitation assays using conditioned medium of HEK293T cells, cells were transfected separately with each plasmid expression vector using the FuGENE6 transfection reagent. After 24 hr, the cells were washed twice with Hank's buffer and cultured in serum-free OptiMEMI (Invitrogen) for another 48 hr. Conditioned media-containing proteins were immunoprecipitated using anti-Flag M2 affinity gel (Sigma) in the presence of 0.1% NP40 and 0.1% BSA. For coprecipitation assays using proteins secreted by Xenopus embryonic cells, mRNA-injected embryos were dissociated using CMFM (calcium/magnesium-free medium) containing 0.1% BSA, and allowed to secrete proteins into the medium during stages 10.5-13 (equivalent). Conditioned medium was subjected to the coprecipitation assay after the concentrations of CaCl 2 (to final 0.9 mM), MgCl 2 (to final 0.33 mM), and NP40 (to final 0.1%) were adjusted. A coprecipitation assay was done using purified proteins or recombinant proteins mixed in Hank's wash buffer (Hank's buffer containing 20 mM HEPES [pH 7.1], 0.1% NP40, and 1 mM ZnCl 2 ) containing 0.1% BSA. The production of Chordin antibodies and information on other recombinant proteins and immunoprecipitation assays are described in Supplemental Experimental Procedures.
In Vivo and In Vitro Chordin Cleavage Assays For in vivo cleavage assays, RNA-injected embryos were collected at stage 12 and dissociated in ice-cold CMFM containing 0.1% BSA, 5 mM EDTA, and protease inhibitor cocktail (EDTA-free; Nacalai Tesque). After centrifugation, the supernatant received NP40 to a final 0.5% concentration and collected as the ''secreted'' fraction. The precipitate was lysed at 4 C in TNE buffer (50 mM Tris-HCl [pH 7.8], 1% NP40, 20 mM EDTA, and 150 mM NaCl) and collected as the ''lysate'' fraction. For in vitro cleavage assays, full-length ONT1 protein was purified from medium conditioned by HEK293T cells transfected with pcDNA6-Flag-ONT1/His (the Flag tag was inserted just after the signal sequence, and the 63 His tag was inserted before the stop codon). Conditioned medium was prepared as described above, and Flag-ONT1/His protein was purified using Ni-NTA agarose beads (QIAGEN). To strictly avoid contamination, the eluted fractions were further purified with anti-Flag M2 affinity gel according to the manufacturer's instructions. Chordin-V5/His and Xlr-Flag protein were also prepared from medium conditioned by HEK293T cells transfected with their expression vectors. For in vitro digestion, purified Flag-ONT1/His, Chordin-V5/His, or XlrFlag was incubated in buffer (10 mM HEPES [pH 7.6], 150 mM NaCl, 2.5 mM CaCl 2 , 1 mM MgCl 2 , and 1 mM ZnCl 2 ; Piccolo et al., 1997) 
